Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Detection of PTEN nonsense mutation and ψPTEN expression in central nervous system high-grade astrocytic tumors by a yeast-based stop codon assay

Abstract

We have developed a new yeast-based assay for the detection of PTEN nonsense mutation, and applied it to a total of 42 astrocytic tumors. The assay utilizes homologous recombination of PCR-amplified PTEN cDNA samples to a yeast vector which expresses an in-frame PTEN::ADE2 chimera protein. An allele of nonsense mutation in the sample PTEN mRNA gives a truncated chimera protein in a yeast cell, resulting in the formation of a red colony. The assay and subsequent sequence analysis demonstrated nonsense mutations as red colonies of more than 10% in one of 10 anaplastic astrocytomas and six of 18 glioblastomas, but none in six pilocytic astrocytomas or in eight astrocytomas. Sequence analysis of white colonies showed one missense mutation in a glioblastoma. Interestingly, four of seven nonsense mutations were frame-shifts due to exon skipping. In addition, pink colonies were found in one of six pilocytic astrocytomas, three of eight astrocytomas, two of 10 anaplastic astrocytomas, and 10 of 18 glioblastomas. Sequence analysis of the pink colonies revealed a sequence similar to those reported as ψPTEN/PTH2. By testing mRNA and genomic DNA, it was found to be a processed pseudogene which was transcribed. The ψPTEN expression was complementary to PTEN mutation, for 14 of 18 glioblastomas showed either PTEN mutation or ψPTEN expression and only one case showed both PTEN mutation and ψPTEN expression (P<0.046), suggesting a pathological role of ψPTEN expression as an alternative to PTEN mutation in glioblastomas.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Andreutti-Zaugg C, Scott RJ and Iggo R. . 1997 Cancer Res. 57: 3288–3293.

  • Ayala FJ. . 1995 Science 270: 1930–1936.

  • Bello MJ, Vaquero J, de Campos JM, Kusak ME, Sarasa JL, Saez-Castresana J, Pestana A and Rey JA. . 1994 Int. J. Cancer 57: 172–175.

  • Boström J, Cobbers JM, Wolter M, Tabatabai G, Weber RG, Lichter P, Collins VP and Reifenberger G. . 1998 Cancer Res. 58: 29–33.

  • Cheney IW, Johnson DE, Vaillancourt MT, Avanzini J, Morimoto A, Demers GW, Wills KN, Shabram PW, Bolen JB, Tavtigian SV and Bookstein R. . 1998 Cancer Res. 58: 2331–2334.

  • Chiariello E, Roz L, Albarosa R, Magnani I and Finocchiaro G. . 1998 Oncogene 16: 541–545.

  • Dahia PL, FitzGerald MG, Zhang X, Marsh DJ, Zheng Z, Pietsch T, von Deimling A, Haluska FG, Haber DA and Eng C. . 1998 Oncogene 16: 2403–2406.

  • Davies MA, Koul D, Dhesi H, Berman R, McDonnell TJ, McConkey D, Yung WK and Steck PA. . 1999 Cancer Res. 59: 2551–2556.

  • Davies MA, Lu Y, Sano T, Fang X, Tang P, LaPushin R, Koul D, Bookstein R, Stokoe D, Yung WK, Mills GB and Steck PA. . 1998 Cancer Res. 58: 5285–5290.

  • Di Cristofano A, Pesce B, Cordoncardo C and Pandolfi PP. . 1998 Nature Genetics 19: 348–355.

  • Flaman J-M, Frebourg T, Moreau V, Charbonnier F, Martin C, Chappuis P, Sappino A-P, Limacher J-M, Brons L, Benhattar J, Tada M, Van Meir EG, Estreicher A and Iggo RD. . 1995 Proc. Natl. Acad. Sci. USA 92: 3963–3967.

  • Furnari FB, Lin H, Huang HJS and Cavenee WK. . 1997 Proc. Natl. Acad. Sci. USA 94: 12479–12484.

  • Haas-Kogan D, Shalev N, Wong M, Mills G, Yount G and Stokoe D. . 1998 Curr. Biol. 8: 1195–1198.

  • Hayashi Y, Ueki K, Waha A, Wiestler OD, Louis DN and von Deimling A. . 1997 Brain Pathol. 7: 871–875.

  • Ishii N, Sawamura Y, Tada M, Daub DM, Janzer RC, Meagher-Villemure K, de Tribolet N and Van Meir EG. . 1998 Int. J. Cancer 76: 797–800.

  • Kim SK, Su LK, Oh Y, Kemp BL, Hong WK and Mao L. . 1998 Oncogene 16: 89–93.

  • Kleihues P, Burger PC and Scheithauer BW. . 1993 Histological Typing of Tumours of the Central Nervous System, 2nd edn. Springer Verlag, Berlin, Heidelberg.

  • Kon H, Sonoda Y, Kumabe T, Yoshimoto T, Sekiya T and Murakami Y. . 1998 Oncogene 16: 257–263.

  • Kong D et al. 1997 Nat. Genet. 17: 143–144.

  • Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH and Parsons R. . 1997 Science 275: 1943–1947.

  • Li WH, Gojobori T and Nei M. . 1981 Nature 292: 237–239.

  • Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, Zheng Z, Bose S, Call KM, Tsou HC, Peacocke M, Eng C and Parsons R. . 1997 Nat. Genet. 16: 64–67.

  • Liu WG, James CD, Frederick L, Alderete BE and Jenkins RB. . 1997 Cancer Res. 57: 5254–5257.

  • Maehama T and Dixon JE. . 1998 J. Biol. Chem. 273: 13375–13378.

  • Maquat LE. . 1995 RNA 1: 453–465.

  • Marsh DJ, Coulon V, Lunetta KL, Rocca SP, Dahia PL, Zheng Z, Liaw D, Caron S, Duboue B, Lin AY, Richardson AL, Bonnetblanc JM, Bressieux JM, Cabarrot MA, Chompret A, Demange L, Eeles RA, Yahanda AM, Fearon ER, Fricker JP, Gorlin RJ, Hodgson SV, Huson S, Lacombe D, LePrat F, Odent S, Touleouse C, Olopade OI, Sobol H, Tishler S, Woods CG, Robinson BG, Weber HC, Parsons R, Peacocke M, Longy M and Eng C. . 1998 Hum. Mol. Genet. 7: 507–515.

  • Marsh DJ, Dahia PL, Zheng Z, Liaw D, Parsons R, Gorlin RJ and Eng C. . 1997 Nat. Genet. 16: 333–334.

  • Matsumoto R, Tada M, Nozaki M, Zhang CL, Sawamura Y and Abe H. . 1998 Cancer Res. 58: 609–613.

  • Mollenhauer J, Wiemann S, Scheurlen W, Korn B, Hayashi Y, Wilgenbus KK, von Deimling A and Poustka A. . 1997 Nat. Genet. 17: 32–39.

  • Myers MP, Pass I, Batty IH, Van der Kaay J, Stolarov JP, Hemmings BA, Wigler MH, Downes CP and Tonks NK. . 1998 Proc. Natl. Acad. Sci. USA 95: 13513–13518.

  • Nakamura H, Yoshida M, Tsuiki H, Ito K, Ueno M, Nakao M, Oka K, Tada M, Kochi M, Kuratsu J-I, Ushio Y and Saya H. . 1998 Oncogene 16: 1009–1019.

  • Olschwang S, Serova Sinilnikova OM, Lenoir GM and Thomas G. . 1998 Nat. Genet. 18: 12–14.

  • Rasheed BK, Stenzel TT, McLendon RE, Parsons R, Friedman AH, Friedman HS, Bigner DD and Bigner SH. . 1997 Cancer Res. 57: 4187–4190.

  • Reifenberger G, Reifenberger J, Ichimura K, Meltzer PS and Collins VP. . 1994 Cancer Res. 54: 4299–4303.

  • Scala S, Bruni P, Lomuzio L, Mignogna M, Viglietto G and Fusco A. . 1998 Internat. J. Oncol. 13: 665–668.

  • Stambolic V, Suzuki A, Delapompa JL, Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM, Siderovski DP and Mak TW. . 1998 Cell 95: 29–39.

  • Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DH and Tavtigian SV. . 1997 Nat. Genet. 15: 356–362.

  • Suzuki A, de la Pompa JL, Stambolic V, Elia AJ, Sasaki T, Barrantes IB, Ho A, Wakeham A, Ltie A, Khoo W, Fukumoto M and Mak TW. . 1998 Curr. Biol. 8: 1169–1178.

  • Tada M, Iggo RD, Waridel F, Nozaki M, Matusmoto R, Sawamura Y, Shinohe Y, Ikeda J and Abe H. . 1997a Mol. Carcinog. 18: 171–176.

  • Tada M, Sawamura Y, Abe H and Iggo R. . 1997b Neurosurgery 40: 393–396.

  • Tamura M, Gu J, Matsumoto K, Aota S-I, Parsons R and Yamada KM. . 1998 Science 280: 1614–1617.

  • Teng DHF, Hu R, Lin H, Davis T, Iliev D, Frye C, Swedlund B, Hansen KL, Vinson VL, Gumpper KL, Ellis L, Elnaggar A, Frazier M, Jasser S, Langford LA, Lee J, Mills GB, Pershouse MA, Pollack RE, Tornos C, Troncoso P, Yung W, Fujii G, Berson A, Bookstein R et al. 1997 Cancer Res. 57: 5221–5225.

  • Tohma Y, Gratas C, Biernat W, Peraud A, Fukuda M, Yonekawa Y, Kleihues P and Ohgaki H. . 1998 J. Neuropathol. Exp. Neurol. 57: 684–689.

  • Tsou HC, Ping XL, Xie XX, Gruener AC, Zhang H, Nini R, Swisshelm K, Sybert V, Diamond TM, Sutphen R and Peacocke M. . 1998 Hum. Genet. 102: 467–473.

  • von Deimling A, Louis DN, von Ammon K, Petersen I, Hoell T, Chung RY, Martuza RL, Schoenfeld DA, Yasargil MG, Wiestler OD and Seizinger BR. . 1992 J. Neurosurg. 77: 295–301.

  • von Deimling A, Nagel J, Bender B, Lenartz D, Schramm J, Louis DN and Wiestler OD. . 1994 Int. J. Cancer 57: 676–680.

  • Wang SI, Puc J, Li J, Bruce JN, Cairns P, Sidransky D and Parsons R. . 1997 Cancer Res. 57: 4183–4186.

  • Weisman LS, Bacallao R and Wickner W. . 1987 J. Cell Biol. 105: 1539–1547.

Download references

Acknowledgements

We thank Drs Yutaka Sawamura, Kenji Mitsumori and Hisatoshi Saito for providing clinical samples, Ms Yumiko Shinohe for her excellent technical assistance and Ms Masako Yanome for her help in preparation of the manuscript.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, CL., Tada, M., Kobayashi, H. et al. Detection of PTEN nonsense mutation and ψPTEN expression in central nervous system high-grade astrocytic tumors by a yeast-based stop codon assay. Oncogene 19, 4346–4353 (2000). https://doi.org/10.1038/sj.onc.1203795

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203795

Keywords

This article is cited by

Search

Quick links